Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $1,005 | 3 | 66.0% |
| Food and Beverage | $518.51 | 7 | 34.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sekisui Diagnostics, LLC | $1,005 | 3 | $0 (2024) |
| Celgene Corporation | $136.33 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $125.12 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $125.00 | 1 | $0 (2024) |
| PTC Therapeutics, Inc. | $107.31 | 1 | $0 (2019) |
| Kite Pharma, Inc. | $24.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $580.05 | 4 | Sekisui Diagnostics, LLC ($280.00) |
| 2023 | $260.00 | 1 | Sekisui Diagnostics, LLC ($260.00) |
| 2022 | $465.00 | 1 | Sekisui Diagnostics, LLC ($465.00) |
| 2019 | $132.06 | 2 | PTC Therapeutics, Inc. ($107.31) |
| 2017 | $86.40 | 2 | Celgene Corporation ($86.40) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $125.12 | General |
| Category: Oncology | ||||||
| 02/24/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $49.93 | General |
| 01/25/2024 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $280.00 | General |
| 01/01/2023 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $260.00 | General |
| 01/01/2022 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $465.00 | General |
| 12/09/2019 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: ONC | ||||||
| 12/07/2019 | PTC Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $107.31 | General |
| 12/10/2017 | Celgene Corporation | CC-486 (Drug) | Food and Beverage | In-kind items and services | $45.62 | General |
| 12/10/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $40.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 70 | $16,454 | $6,544 |
| 2022 | 5 | 121 | 290 | $99,148 | $24,442 |
| 2021 | 4 | 112 | 234 | $66,802 | $20,600 |
| 2020 | 4 | 108 | 240 | $56,454 | $15,883 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 52 | $13,178 | $5,326 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $3,276 | $1,218 | 37.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 156 | $61,620 | $12,350 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 42 | 77 | $18,788 | $7,557 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 23 | 25 | $4,550 | $1,699 | 37.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $8,415 | $1,681 | 20.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 21 | $5,775 | $1,155 | 20.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 52 | 101 | $24,644 | $10,457 | 42.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 77 | $30,030 | $6,231 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 26 | 34 | $6,188 | $2,673 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 22 | $5,940 | $1,239 | 20.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 41 | 117 | $21,294 | $6,407 | 30.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 63 | $23,310 | $5,294 | 22.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 20 | 29 | $7,076 | $2,249 | 31.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 22 | 31 | $4,774 | $1,932 | 40.5% |
About Dr. Michael Becker, MD
Dr. Michael Becker, MD is a Internal Medicine healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689692691.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Becker, MD has received a total of $1,524 in payments from pharmaceutical and medical device companies, with $580.05 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Gift" ($1,005).
As a Medicare-enrolled provider, Becker has provided services to 387 Medicare beneficiaries, totaling 834 services with total Medicare billing of $67,469. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology, Medical Oncology
- Location Columbus, OH
- Active Since 07/17/2006
- Last Updated 02/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689692691
Products in Payments
- KYMRIAH (Drug) $125.12
- ICLUSIG (Drug) $125.00
- CC-486 (Drug) $45.62
- Yescarta (Drug) $24.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Columbus
Anish Amin, M.d, M.D
Internal Medicine — Payments: $807,022
Dr. Alexa Meara, Md, MD
Internal Medicine — Payments: $377,655
Jayanta Mukherjee, Md, MD
Internal Medicine — Payments: $240,062
Dr. David Lo, M.d, M.D
Internal Medicine — Payments: $185,475
Narendranath Epperla, Md, MD
Internal Medicine — Payments: $184,240
Lucy Laperna, Do, DO
Internal Medicine — Payments: $133,632